Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 154 results for "mahantesh"

Oil companies look fundamentally attractive: Mahantesh Sabarad...

In an interview with ET Now, Mahantesh Sabarad, Deputy Head Research, SBI Cap Securities, shares his views on markets. Excerpts: ET Now: What is the view coming in for the general perspective on the markets, given all that is going on globally as ... Economic Times, 3 weeks ago

4 images for mahantesh

Daiji World, 4 months ago
Daiji World, 4 months ago
SahiOnline, 5 months ago
SahiOnline, 5 months ago

Buy Sun Pharmaceutical Industries: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities recommends buying Sun Pharmaceutical Industries.
 Money Control4 weeks ago Hold IndusInd Bank, says Mahantesh Sabarad  Money Control2 months ago Buy Sun Pharma for long term: Mahantesh Sabarad  Money Control2 months ago Mahantesh Sabarad positive on YES Bank  Money Control2 months ago

Earnings Downgrade Likely Going Ahead: SBICAP Securities

|Duration: 16 min, 20 sec Mahantesh Sabard, deputy head of research with SBICAP Securities told NDTV that from structural perspective bottom formation process for the Nifty has begun and earnings trajectory is likely to improve but he points out ...
 NDTV1 month ago RBI rate cut next trigger for mkt; buy Jubilant: SBICap Sec  Money Control1 month ago

Buy Tata Motors, advises Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities is of the view that Tata Motors is worth buying into.
 Money Control4 weeks ago

Prefer UltraTech Cement, Bank of Baroda: Mahantesh Sabarad

Mahantesh Sabarad - Deputy VP - Research at SBI Capital Securities is of the view that one may prefer UltraTech Cement and Bank of Baroda.
 Money Control1 month ago

Buy Jubilant Life Sciences , advises Mahantesh Sabarad

Mahantesh Sabarad - Deputy VP - Research at SBI Capital Securities recommends buying Jubilant Life Sciences.
 Money Control1 month ago

Banks can't be a blanket call; investors need to weigh each bank individually: Mahantesh Sabarad, SBI Cap Sec

Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must Log In/Connect with: Indiatimes Network or Fill in your details: Will be displayed Will not be displayed Will ...
 Economic Times1 month ago

Look at Voltas, Blue Star: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may look at Voltas and Blue Star.
 Money Control2 months ago

Here are Mahantesh Sabarad's few trading ideas

Watch the interview of Mahantesh Sabarad, Dy VP – Research at SBICap Securities with Anuj Singhal Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
 Money Control2 months ago

Cops find evidence against ex-ZP chief in Bengaluru

BENGALURU: The Criminal Investigation Department (CID) probing the killing of Yallalinga Kuruba, 17, a class XII student of Koppal district, north Karnataka, found that the prime accused, former zilla panchayat president Hanumesh Nayak, was ...
 Times of India2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less